X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with J.B.Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB J.B.CHEMICALS UNICHEM LAB/
J.B.CHEMICALS
 
P/E (TTM) x 29.7 14.7 201.8% View Chart
P/BV x 3.1 2.3 134.3% View Chart
Dividend Yield % 0.6 0.2 364.8%  

Financials

 UNICHEM LAB   J.B.CHEMICALS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
J.B.CHEMICALS
Mar-16
UNICHEM LAB/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs334318 105.0%   
Low Rs174200 87.2%   
Sales per share (Unadj.) Rs146.9148.0 99.3%  
Earnings per share (Unadj.) Rs11.919.1 62.3%  
Cash flow per share (Unadj.) Rs16.223.9 67.6%  
Dividends per share (Unadj.) Rs2.000.50 400.0%  
Dividend yield (eoy) %0.80.2 407.6%  
Book value per share (Unadj.) Rs105.1128.9 81.5%  
Shares outstanding (eoy) m90.8484.82 107.1%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.71.7 98.9%   
Avg P/E ratio x21.413.6 157.5%  
P/CF ratio (eoy) x15.710.8 145.2%  
Price / Book Value ratio x2.42.0 120.4%  
Dividend payout %16.82.6 641.8%   
Avg Mkt Cap Rs m23,07321,951 105.1%   
No. of employees `0005.72.7 207.5%   
Total wages/salary Rs m2,5581,841 138.9%   
Avg. sales/employee Rs Th2,352.54,590.9 51.2%   
Avg. wages/employee Rs Th450.9673.4 67.0%   
Avg. net profit/employee Rs Th190.4592.1 32.2%   
INCOME DATA
Net Sales Rs m13,34612,551 106.3%  
Other income Rs m192542 35.4%   
Total revenues Rs m13,53813,093 103.4%   
Gross profit Rs m1,6392,055 79.8%  
Depreciation Rs m390412 94.6%   
Interest Rs m2996 30.1%   
Profit before tax Rs m1,4122,088 67.6%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m293469 62.4%   
Profit after tax Rs m1,0801,619 66.7%  
Gross profit margin %12.316.4 75.0%  
Effective tax rate %20.722.5 92.3%   
Net profit margin %8.112.9 62.8%  
BALANCE SHEET DATA
Current assets Rs m5,9797,778 76.9%   
Current liabilities Rs m2,4324,358 55.8%   
Net working cap to sales %26.627.2 97.6%  
Current ratio x2.51.8 137.8%  
Inventory Days Days6355 115.4%  
Debtors Days Days6080 75.4%  
Net fixed assets Rs m6,4035,713 112.1%   
Share capital Rs m182170 107.1%   
"Free" reserves Rs m9,29310,547 88.1%   
Net worth Rs m9,54810,937 87.3%   
Long term debt Rs m2300-   
Total assets Rs m12,84315,574 82.5%  
Interest coverage x50.022.8 219.2%   
Debt to equity ratio x00-  
Sales to assets ratio x1.00.8 128.9%   
Return on assets %8.611.0 78.5%  
Return on equity %11.314.8 76.5%  
Return on capital %14.320.0 71.8%  
Exports to sales %29.248.7 60.0%   
Imports to sales %6.37.1 89.6%   
Exports (fob) Rs m3,9006,115 63.8%   
Imports (cif) Rs m847889 95.3%   
Fx inflow Rs m4,3566,169 70.6%   
Fx outflow Rs m1,1621,285 90.4%   
Net fx Rs m3,1944,884 65.4%   
CASH FLOW
From Operations Rs m1,1191,397 80.1%  
From Investments Rs m-853-320 266.4%  
From Financial Activity Rs m-334-1,196 27.9%  
Net Cashflow Rs m-68-102 66.8%  

Share Holding

Indian Promoters % 50.1 55.4 90.4%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 15.1 3.4 445.4%  
FIIs % 3.0 3.9 76.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 37.0 85.7%  
Shareholders   20,176 30,437 66.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Feb 19, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS